Last10K.com

Nexgel, Inc. (1468929) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020

Aquamed Technologies, Inc.

CIK: 1468929
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2020
Mar. 30, 2021
Jun. 30, 2020
Document and Entity Information   
Document Type10-K  
Document Period End DateDec. 31, 2020  
Entity Registrant NameNEXGEL, INC.  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companytrue  
Entity Ex Transition Periodfalse  
Entity Shell Companyfalse  
Entity Common Stock, Shares Outstanding 102,893,779 
Title of 12(g) SecurityCommon Stock, $0.001 par value  
Entity Central Index Key0001468929  
Current Fiscal Year End Date--12-31  
Document Fiscal Year Focus2020  
Document Fiscal Period FocusFY  
Amendment Flagfalse  
Entity Well Known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Public Float  $ 0

View differences made from one year to another to evaluate Aquamed Technologies, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aquamed Technologies, Inc..

Continue

Assess how Aquamed Technologies, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aquamed Technologies, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Balance Sheets
Balance Sheets (Parenthetical)
Statements Of Cash Flows
Statements Of Operations
Statements Of Stockholders' Equity
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (Details)
Accrued Expenses And Other Current Liabilities (Tables)
Acquisition
Acquisition (Details)
Acquisition (Tables)
Acquisition - Preliminary Analysis (Details)
Acquisition - Pro-Forma Results (Details)
Common Stock
Common Stock (Tables)
Common Stock - Additional Information (Details)
Common Stock - Common Stock Reserved For Issuance (Details)
Concentration Of Risk
Concentration Of Risk (Details)
Convertible Notes Payable
Convertible Notes Payable (Details)
Description Of Business, The Spin-Off And Basis Of Presentation
Description Of Business, The Spin-Off And Basis Of Presentation (Details)
Description Of Business, The Spin-Off And Basis Of Presentation (Tables)
Going Concern
Going Concern (Details)
Going Concern - Share Purchase Agreement (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Provision Of Income Tax (Benefit) (Details)
Income Taxes - Reconciliation Of Tax Benefit On Stautory Rate (Details)
Income Taxes - Schedule Of Deferred Tax Assets And Liabilities (Details)
Intangible Assets
Intangible Assets (Tables)
Intangible Assets - Additional Information (Details)
Intangible Assets - Breakdown Of Identifiable Intangible Assets (Details)
Intangible Assets - Future Amortization Expense (Details)
Inventory
Inventory (Details)
Inventory (Tables)
Leases
Leases (Tables)
Leases - Additional Information (Details)
Leases - Future Minimum Lease Payments (Details)
Leases - Supplemental Cash Flows Information (Details)
Net Loss Per Common Share
Net Loss Per Common Share (Details)
Note Payable
Note Payable (Details)
Property And Equipment, Net
Property And Equipment, Net (Details)
Property And Equipment, Net (Tables)
Property And Equipment, Net - Additional Information (Details)
Related Party Transactions
Related Party Transactions (Details)
Share-Based Compensation
Share-Based Compensation (Tables)
Share-Based Compensation - 2019 Plan (Details)
Share-Based Compensation - Additional Information (Details)
Share-Based Compensation - Assumptions (Details)
Share-Based Compensation - Option Activity (Details)
Share-Based Compensation - Restrictive Stock Awards (Details)
Share-Based Compensation - Warrants (Details)
Significant Accounting Policies And Estimates
Significant Accounting Policies And Estimates (Details)
Significant Accounting Policies And Estimates (Policies)
Subsequent Events
Subsequent Events (Details)
Warrant Liability
Warrant Liability (Details)
Warrant Liability (Tables)
CIK: 1468929
Form Type: 10-K Annual Report
Accession Number: 0001104659-21-044842
Submitted to the SEC: Wed Mar 31 2021 4:58:30 PM EST
Accepted by the SEC: Wed Mar 31 2021
Period: Thursday, December 31, 2020
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/1468929/0001104659-21-044842.htm